EDIT

Editas Medicine, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.21

+0.01 (+0.16%)

Rating:C-

Company Profile

CEO

Gilmore O'Neill

IPO Date

2016-02-03

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$3.21

Prev. Close

$3.20

Day Low

$3.11

Day High

$3.27

52W Low

$1.66

52W High

$4.54

Market Cap

$0.31B

Volume

0.81M

News SentimentBullish

Articles

Avg Positive

29.8%

Avg Negative

14.0%

Avg Neutral

56.2%

News Feed

Editas: Gene Therapy Specialist Leading The Way In Eye Disease

Seeking Alpha·8/27/2021·↑ positive

Editas Medicine Unveils Preclinical Data From New Gene Editing Technology

Benzinga·8/23/2021·↑ positive

Editas Medicine Presents Data on New SLEEK Gene Editing Technology at Cold Spring Harbor Laboratory's Genome Engineering: CRISPR Frontiers Meeting

GlobeNewsWire